DrugPatentWatch Database Preview
Profile for United States of America Patent: 2005222144
US Patent Family Members and Approved Drugs for United States of America Patent: 2005222144
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Nov 10, 2023 | Boehringer Ingelheim | STIOLTO RESPIMAT | olodaterol hydrochloride; tiotropium bromide |
➤ Sign Up | Nov 10, 2023 | Boehringer Ingelheim | STRIVERDI RESPIMAT | olodaterol hydrochloride |
➤ Sign Up | Dec 7, 2023 | Boehringer Ingelheim | STIOLTO RESPIMAT | olodaterol hydrochloride; tiotropium bromide |
➤ Sign Up | Dec 7, 2023 | Boehringer Ingelheim | STRIVERDI RESPIMAT | olodaterol hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |